Paper21908511
Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines.
Mandalà M and 3 others. Ann Oncol, 2011. Cited by 388 papers, by iCite.
Cite this record
ConductScience Library. Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines. Papers, record 21908511. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21908511
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines.
- PubMed
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Venous Thromboembolism | Major topic |
| Humans | |
| Risk Factors |
Source PubMed
Cited by196
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 388 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42452460 | Hematological Changes Associated with Thrombotic Events in Cancer Patients: A Retrospective Exploratory Study. | J Clin Med | 2026 | https://conductscience.org/library/papers/42452460 | PubMed |
| 41914578 | Predicting Catheter-Related Thrombosis in Colorectal Cancer Patients Using Clinical Features in 730 Patients. | Clin Appl Thromb Hemost | 2026 | https://conductscience.org/library/papers/41914578 | PubMed |
| 41886514 | Integrating multimodal management and molecular profiling in a patient with BRAF V600E-positive melanoma and brain metastases. | CA Cancer J Clin | 2026 | https://conductscience.org/library/papers/41886514 | PubMed |
| 41286902 | Cancer-Associated Thrombosis (CAT); mechanisms and treatment options. | Thromb J | 2025 | https://conductscience.org/library/papers/41286902 | PubMed |
| 40657303 | Predicting thrombotic risk in patients with classical Hodgkin lymphoma: Thro-HL multicenter study. | Hemasphere | 2025 | https://conductscience.org/library/papers/40657303 | PubMed |
| 40231674 | In Vivo pharmacokinetic interactions of ribociclib with rivaroxaban and apixaban in rats: implications for increased drug exposure and dose adjustments. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40231674 | PubMed |
| 40025462 | The reporting quality and methodological quality of dynamic prediction models for cancer prognosis. | BMC Med Res Methodol | 2025 | https://conductscience.org/library/papers/40025462 | PubMed |
| 39618864 | Thromboembolism in Patients with Cancer: A Practical Guide to Recurrent Events. | Rev Cardiovasc Med | 2024 | https://conductscience.org/library/papers/39618864 | PubMed |
| 39171143 | Successful direct oral anticoagulant management of asymptomatic superior mesenteric vein thrombosis after adjuvant chemotherapy for colorectal cancer patient: A case report. | Exp Ther Med | 2024 | https://conductscience.org/library/papers/39171143 | PubMed |
| 39170627 | Analysis of thromboembolism and prognosis in metastatic pancreatic cancer from the Tokushukai REAl‑world data project. | Mol Clin Oncol | 2024 | https://conductscience.org/library/papers/39170627 | PubMed |
| 39090424 | Impact of COVID-19 in the incidence of venous thromboembolism (VTE) and clinical outcomes in cancer patients: a cohort study. | Clin Transl Oncol | 2025 | https://conductscience.org/library/papers/39090424 | PubMed |
| 39060847 | Hypercoagulable state and effect of low-molecular-weight heparin prophylaxis on coagulation after lung cancer resection: results from thrombo-elastography. | Gen Thorac Cardiovasc Surg | 2025 | https://conductscience.org/library/papers/39060847 | PubMed |
| 38939521 | Predicting venous thromboembolism (VTE) risk in cancer patients using machine learning. | Health Care Sci | 2023 | https://conductscience.org/library/papers/38939521 | PubMed |
| 38643312 | Primary thromboprophylaxis in cancer outpatients - real-world evidence. | J Thromb Thrombolysis | 2024 | https://conductscience.org/library/papers/38643312 | PubMed |
| 38529183 | Unlocking the potential of fondaparinux: guideline for optimal usage and clinical suggestions (2023). | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38529183 | PubMed |
| 38178702 | Prevention of symptomatic pulmonary embolism for gynecologic malignancies with preoperative asymptomatic venous thromboembolism: GOTIC-VTE trial. | J Gynecol Oncol | 2024 | https://conductscience.org/library/papers/38178702 | PubMed |
| 38136433 | Non-Vitamin K Antagonist Oral Anticoagulants versus Low Molecular Weight Heparin for Cancer-Related Venous Thromboembolic Events: Individual Patient Data Meta-Analysis. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/38136433 | PubMed |
| 37738366 | Clinical impact of routine response assessment after preoperative chemotherapy in patients with gastric cancer. | BJS Open | 2023 | https://conductscience.org/library/papers/37738366 | PubMed |
| 37278934 | Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism. | Curr Oncol Rep | 2023 | https://conductscience.org/library/papers/37278934 | PubMed |
| 36795409 | Validation of the ONKOTEV Risk Prediction Model for Venous Thromboembolism in Outpatients With Cancer. | JAMA Netw Open | 2023 | https://conductscience.org/library/papers/36795409 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21908511
GET https://conductscience.org/api/papers/v1/21908511/cited_by?page=2